Imron Aly is an experienced IP litigator at ArentFox Schiff. Working with industry-leading clients in pharma and tech, Aly is viewed as a go-to trial lawyer specifically regarding patent infringement. Aly works on a range of IP matters including medical devices, financial trading systems and computer business methods, often dealing with highly complex cross-jurisdictional work.
Intellectual property in United States
ArentFox Schiff
Principaux clients
Nexus Pharmaceuticals, Inc.
Fresenius Kabi USA, LLC
Alkem Laboratories Ltd.
Gland Pharma Ltd.
Hikma Pharmaceuticals
Maia Pharma
Principaux dossiers
- Leveraged claim construction to exploit potential non-infringement arguments in defense of some of the asserted claims to obtain approval for and market a generic version of an intravenous drug.
- Successfully argued that claim terms were not properly defined therefore winning a judgement of invalidity, helping Nexus pursue a generic version for patients.
TottisLaw
Kevin Tottis , founding partner of TottisLaw , has first‑chaired numerous complex commercial and IP cases, representing diverse clients such as manufacturers, consumer brands, educational institutions, and nonprofits. A seasoned appellate advocate, Tottis has successfully led high-impact IP matters, including dramatic rights arbitration, complex trademark disputes and briefing before the Supreme Court on key copyright issues, and is also sought-after as an arbitrator.